JPMorgan raised its quarterly dividend 10% to $1.65. Sixteen of 28 analysts rate the stock a Buy, but the October earnings report will test whether results support the payout.
Shareholders of record at the close of business on October 6 are due to receive JPMorgan Chase's $1.65 dividend payment on October 31. The bank approved the 10% increase on September 15, raising the quarterly payout from $1.50 per share. The next report, scheduled for October 13, will be the first major test after second-quarter results.
MarketBeat counted 16 Buy ratings and 12 Hold ratings among 28 analysts on October 2. Its average one-year price target was $363.29. The reported NYSE price was $331.36 at 11:03 a.m. ET that day. That target implies 9.65% upside from the reference price. It is an estimate, not a promised return or a measure of the dividend's contribution.
At $1.65 per quarter, JPMorgan's dividend annualizes to $6.60 per share, up from $6.00 at the previous quarterly rate.
The market quotes use different currencies and venues. At 5:01 p.m. CEST on October 2, JPMorgan traded at €294.65 on Lang & Schwarz, down 0.53% from €296.23. The NYSE quote was $331.36 earlier that day. They are not comparable as simultaneous prices or as prices in the same currency. The reported 52-week range was $279.10 to $366.50. JPMorgan's market capitalization was $887.9 billion.
Late-September market summaries continued to show the October 31 payment date. The dividend alone does not establish the stock's total return. Share-price changes matter, and future results remain central to judging whether the payout can last. The payment date is set.
Second-quarter figures gave investors a strong headline, along with reasons to look closer. JPMorgan reported $21.20 billion in net income and diluted earnings per share of $7.70. Revenue was $57.30 billion, while net interest income was $25.60 billion. Equities trading revenue rose 86% year over year to $6.00 billion. Net income also included a one-time gain from the bank's Visa stake. That gain should not be treated as a clean measure of recurring earnings power.
Market coverage linked the increase to JPMorgan's capital-return plan and its outlook following CCAR. The higher dividend was described as intended to take effect in the third quarter.
JPMorgan's September 17 investor-relations release said the October 13 results were expected at approximately 7:00 a.m. ET. An 8:30 a.m. ET conference call will follow. Investors will get fresh figures on net interest income and capital-markets activity, which they can compare with the second quarter. As of June 30, JPMorgan had $5.00 trillion in assets and $375.00 billion in stockholders' equity. Its substantial balance sheet backs businesses in consumer, commercial and investment banking, as well as asset and wealth management. Separately, a Reuters-distributed notice recorded a dividend declaration for JPMorgan ETFs Ireland ICAV in an ETF dividend notice.
Investors often focus on cash returned to shareholders. But a higher payout does not remove earnings risks. Reuters-distributed notices also reported dividend declarations for other JPMorgan-related entities, including JPMorgan China Growth & Income. Those notices concern separate entities, not an additional parent-bank dividend. The China fund dividend declaration was one such notice. A similar tension between a dividend increase and underlying business performance appeared in this Altria payout analysis. For JPMorgan, the main question is whether operating results can support both the dividend and the bank's broader capital needs.
A dividend is one part of an investment's return. It cannot replace an assessment of the business or the price paid for the shares. The announced payment gives eligible shareholders a defined cash distribution. It says nothing by itself about future share-price performance. The increase is a credible sign of confidence in JPMorgan's current capital position, but the second-quarter Visa gain makes the October results especially important. Investors should weigh the raise against recurring earnings and the next update on net interest income. An analyst target or a larger check is not proof that the stock has further to run.
